argenx SE (ARGX)
NASDAQ: ARGX · Real-Time Price · USD
690.32
+16.52 (2.45%)
At close: Aug 4, 2025, 4:00 PM
687.24
-3.08 (-0.45%)
After-hours: Aug 4, 2025, 4:41 PM EDT
Blueprint Medicines Market Cap
argenx SE has a market cap or net worth of $41.60 billion as of August 4, 2025. Its market cap has increased by 50.62% in one year.
Market Cap
41.60B
Enterprise Value
37.77B
1-Year Change
50.62%
Ranking
Category
Stock Price
$690.32
Market Cap Chart
Since May 18, 2017, argenx SE's market cap has increased from $618.00M to $41.60B, an increase of 6,630.99%. That is a compound annual growth rate of 66.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2025 | 42.13B | 14.57% |
| Dec 31, 2024 | 36.77B | 72.75% |
| Dec 29, 2023 | 21.29B | 2.05% |
| Dec 30, 2022 | 20.86B | 15.89% |
| Dec 31, 2021 | 18.00B | 29.92% |
| Dec 31, 2020 | 13.85B | 126.49% |
| Dec 31, 2019 | 6.12B | 96.21% |
| Dec 31, 2018 | 3.12B | 83.75% |
| Dec 29, 2017 | 1.70B | 174.53% |
| May 18, 2017 | 618.00M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 690.36B |
| Johnson & Johnson | 411.92B |
| AbbVie | 348.32B |
| AstraZeneca | 229.32B |
| Novartis AG | 226.38B |
| Abbott Laboratories | 226.14B |
| UnitedHealth Group | 218.60B |
| Novo Nordisk | 215.34B |